Evidence map›Paper›PMID 26132906›Full record

ArticleMolecules (Basel, Switzerland)2015

The Anticancer, Antioxidant and Antimicrobial Properties of the Sesquiterpene β-Caryophyllene from the Essential Oil of Aquilaria crassna.

Saad S Dahham, Yasser M Tabana, Muhammad A Iqbal, Mohamed B K Ahamed, Mohammed O Ezzat, Aman S A Majid, Amin M S A Majid

Open access · goldAbstract read
In one paragraph

Article in Molecules (Basel, Switzerland), 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 299 papers.

0numbers the graph read from it
0cells of the map it votes in
299citing papers in PubMed
16.9field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

299 citing papers in PubMed, 797 citations in OpenAlex.

  1. Trial
  2. Article
  3. Article
  4. Article
  5. Pinostrobin pentanoate as a selective estrogen receptor-Research in pharmaceutical sciences · 2026
    Article
  6. Review
  7. Article
  8. Article
  9. Article
  10. Article
  11. Chemical Compositions ofPlants (Basel, Switzerland) · 2026
    Article
  12. Review
  13. Article
  14. Article
  15. Review
  16. Article
  17. Antibacterial Activity of Hydroethanolic Extracts ofAntibiotics (Basel, Switzerland) · 2026
    Article
  18. Article
  19. Article
  20. Essential Oil ofPlants (Basel, Switzerland) · 2026
    Review

239 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 1 institution in 1 country.

Saad S DahhamEMAN Research and Testing Laboratory, School of Pharmaceutical Sciences, Universiti Sains Malaysia, 11800 Minden, Pulau Pinang, Malaysia. hawk_dijla@yahoo.com.
Yasser M TabanaEMAN Research and Testing Laboratory, School of Pharmaceutical Sciences, Universiti Sains Malaysia, 11800 Minden, Pulau Pinang, Malaysia. yasser.tabana@hotmail.com.
Muhammad A IqbalSchool of Chemical Sciences, Universiti Sains Malaysia, 11800 Minden, Pulau Pinang, Malaysia. adnan_chem38@yahoo.com.
Mohamed B K AhamedEMAN Biodiscoveries Sdn. Bhd. EUREKA Complex, Universiti Sains Malaysia (USM) Campus, 11800 Minden, Pulau Pinang, Malaysia. khadeer.nc@gmail.com.
Mohammed O EzzatCentre for Drug Research, Universiti Sains Malaysia, 11800 Minden, Pulau Pinang, Malaysia. mohamed_oday@yahoo.com.
Aman S A MajidAdvanced Medical and Dental Institute (IPPT), Universiti Sains Malaysia, Bertam, 13200 Kepala Batas, Penang, Malaysia. aminmalikshah@gmail.com.
Amin M S A MajidEMAN Research and Testing Laboratory, School of Pharmaceutical Sciences, Universiti Sains Malaysia, 11800 Minden, Pulau Pinang, Malaysia. aminmalikshah@gmail.com.
Universiti Sains Malaysia · MY

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The present study reports a bioassay-guided isolation of β-caryophyllene from the essential oil of Aquilaria crassna. The structure of β-caryophyllene was confirmed using FT-IR, NMR and MS. The antimicrobial effect of β-caryophyllene was examined using human pathogenic bacterial and fungal strains. Its anti-oxidant properties were evaluated by DPPH and FRAP scavenging assays. The cytotoxicity of β-caryophyllene was tested against seven human cancer cell lines. The corresponding selectivity index was determined by testing its cytotoxicity on normal cells. The effects of β-caryophyllene were studied on a series of in vitro antitumor-promoting assays using colon cancer cells. Results showed that β-caryophyllene demonstrated selective antibacterial activity against S. aureus (MIC 3 ± 1.0 µM) and more pronounced anti-fungal activity than kanamycin. β-Caryophyllene also displayed strong antioxidant effects. Additionally, β-caryophyllene exhibited selective anti-proliferative effects against colorectal cancer cells (IC50 19 µM). The results also showed that β-caryophyllene induces apoptosis via nuclear condensation and fragmentation pathways including disruption of mitochondrial membrane potential. Further, β-caryophyllene demonstrated potent inhibition against clonogenicity, migration, invasion and spheroid formation in colon cancer cells. These results prompt us to state that β-caryophyllene is the active principle responsible for the selective anticancer and antimicrobial activities of A. crassnia. β-Caryophyllene has great potential to be further developed as a promising chemotherapeutic agent against colorectal malignancies.

Indexed as

Anti-Infective AgentsAntineoplastic AgentsAntioxidantsCell Line, TumorDrug Screening Assays, AntitumorHumansMicrobial Sensitivity TestsMolecular StructureOils, VolatilePolycyclic SesquiterpenesSesquiterpenesThymelaeaceaeAnti-Infective AgentsAntineoplastic AgentsAntioxidantscaryophylleneOils, VolatilePolycyclic SesquiterpenesSesquiterpenesanti-canceranti-clonogenicapoptosiscolorectal cancernuclear fragmentationβ-caryophyllene

Identifiers

PMID26132906
PMCPMC6331975
OpenAlexW1629950689

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.